Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
09 2022
Historique:
entrez: 30 9 2022
pubmed: 1 10 2022
medline: 4 10 2022
Statut: ppublish

Résumé

While two influenza B virus lineages have co-circulated, B/Yamagata-lineage circulation has not been confirmed since March 2020. The WHO FluNet database indicates that B/Yamagata-lineage detections were reported in 2021 and 2022. However, detections can result from use of quadrivalent live-attenuated vaccines. Of the type B viruses detected post-March 2020, all ascribed to a lineage have been B/Victoria-lineage. There is need for a global effort to detect and lineage-ascribe type B influenza viruses, to assess if B/Yamagata-lineage viruses have become extinct.

Identifiants

pubmed: 36177871
doi: 10.2807/1560-7917.ES.2022.27.39.2200753
pmc: PMC9524051
doi:

Substances chimiques

Influenza Vaccines 0
Vaccines, Attenuated 0
Vaccines, Combined 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

MMWR Morb Mortal Wkly Rep. 2022 Jul 22;71(29):913-919
pubmed: 35862284
J Med Microbiol. 2012 Mar;61(Pt 3):332-338
pubmed: 22096134
Sci Rep. 2019 Nov 29;9(1):17965
pubmed: 31784567
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):619-628
pubmed: 31843889
J Med Microbiol. 2015 Apr;64(Pt 4):466-468
pubmed: 25657303
Clin Vaccine Immunol. 2011 Mar;18(3):469-76
pubmed: 21209157
Elife. 2015 Jan 16;4:e05055
pubmed: 25594904
Infect Dis Poverty. 2022 Jun 29;11(1):74
pubmed: 35768826
Nat Commun. 2022 Mar 31;13(1):1721
pubmed: 35361789
PLoS One. 2019 Sep 12;14(9):e0222381
pubmed: 31513690

Auteurs

John Paget (J)

Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.

Saverio Caini (S)

Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.

Marco Del Riccio (M)

Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.
University of Florence, Florence, Italy.

Willemijn van Waarden (W)

Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands.

Adam Meijer (A)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH